医薬品用温度制御包装の世界市場：製品・タイプ・温度範囲・可搬質量・用途・医薬品タイプ・エンドユーザー産業・地域別の予測 (～2030年)

医薬品用温度制御包装の市場規模は予測期間中に9.2%のCAGRで成長すると予測されています。

医薬品用温度制御包装の市場は、製薬業の成長、インテリジェントコールドチェーン技術の採用、地域の製薬業界を支援するためのさまざまな政府の取り組みによって牽引されています。

医薬品向け温度制御包装市場の拡大は、医薬品業界における包装需要の増加によって促進されています。医薬品用温度制御包装は、繊細な製品が適切な温度に維持されることを保証することを目的としています。ヘルスケア産業は、温度に敏感な製品を温度管理された環境で輸送・保管するための包装ソリューションの主な用途です。

地域別展望

北米市場は2023年に最大の市場シェアを占め、予測期間中はもっとも高いCAGRが見込まれています。北米は可処分所得水準が高く、多くの患者が存在し、さまざまな生活習慣病があることから、予測期間中は収益性の高い市場になる見通しです。老年人口の拡大と医薬品の安全性規制も地域市場の需要を増加させる可能性があります。国際貿易や二国間貿易協定の増加も市場にとって有利に働く可能性があります。

アジア太平洋地域は第2位のシェアを占めています。予測期間中、収益ベースのCAGRで増加すると予想されています。同地域は、感染症の増加とワクチン保存のためのコールドチェーンソリューションの必要性から、収益性が高いと考えられています。財務収益を最適化するため、業界の主要企業は、将来性の高いアジア諸国に集中する可能性があります。

当レポートでは、世界の医薬品用温度制御包装の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 成長パラメータのマッピング：促進要因
  • 医薬品業界の成長
  • よりスマートなコールドチェーン技術の導入
• 業界関係者が直面している課題
  • 原材料費の上昇
• 機会
  • 製薬産業の活性化のための各国政府による取り組み
• COVID-19の影響分析

第5章 市場要因分析

• サプライ/バリューチェーン分析
• ポーターのファイブフォース分析

第6章 世界の医薬品用温度制御包装市場：製品別

• シッパー
• コンテナ

第7章 世界の医薬品用温度制御包装市場：タイプ別

• 自動車
• アクティブシステム
• パッシブシステム

第8章 世界の医薬品用温度制御包装市場：温度範囲別

• -20°C以下
• -20℃～0℃
• 2℃～8℃
• 8°C～25°C
• 25℃以上

第9章 世界の医薬品用温度制御包装市場：積載量別

• 最大10L
• 10-20L
• 20-40L
• 40-150L
• 150L以上

第10章 世界の医薬品用温度制御包装市場：用途別

• 使い捨て
• 再利用可能

第11章 世界の医薬品用温度制御包装市場：医薬品タイプ別

• 温度に敏感な医薬品
• ワクチン
• 再生医療

第12章 世界の医薬品用温度制御包装市場：エンドユーザー産業別

• 医薬品
• 臨床試験

第13章 世界の医薬品用温度制御包装市場：地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第14章 競合情勢

• 競合ダッシュボード
• 企業市場シェア分析
• 市場のディスラプターとイノベーター
• 市場リーダーの採用戦略
• 開発件数でトップの企業
• 競合ベンチマーキング
• 公開企業の株式概要
• 比較分析：主要企業の財務動向
• 主な展開・成長戦略

第15章 企業プロファイル

• COLD CHAIN TECHNOLOGIES, LLC
• EMBALL'ISO
• INMARK, LLC
• SONOCO THERMOSAFE
• VA-Q-TEC AG
• DEUTSCHE BAHN AG
• DHL INTERNATIONAL GMBH
• KUEHNE+NAGEL INC.
• UNITED PARCEL SERVICE OF AMERICA, INC.
• KANEKA CORPORATION
• CSAFE GLOBAL

第16章 推奨事項と専門家の見解

• 市場の短期的見通し・長期的見通し
• 注目の企業
• 今後数年間の製品構成

第17章 MRFRの提供内容とチーム

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS
• TABLE 2 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT 2018-2030 (USD MILLION)
• TABLE 3 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 4 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 5 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 6 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 7 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 8 REGENERATIVE MEDICINE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 9 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 10 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 12 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 14 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 15 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 16 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 17 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 18 REGENERATIVE MEDICINE: NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 19 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 20 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 22 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 23 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 24 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 25 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 26 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 27 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 28 CANADATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 30 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 31 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 32 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 33 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 34 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 35 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 36 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 39 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 40 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 41 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 42 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 43 REGENERATIVE MEDICINE: EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 44 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 45 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 47 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 48 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 49 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 50 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 51 REGENERATIVE MEDICINE: GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 52 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 53 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 55 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 56 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 57 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 58 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 59 REGENERATIVE MEDICINE: FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 60 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 61 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 63 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 64 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 65 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 66 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 67 REGENERATIVE MEDICINE: UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 68 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 69 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 71 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 72 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 73 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 74 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 75 REGENERATIVE MEDICINE: ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 76 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 77 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 79 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 80 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 81 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 82 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 83 REGENERATIVE MEDICINE: SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 84 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 85 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 87 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 88 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 89 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 90 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 91 REGENERATIVE MEDICINE: REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 92 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 93 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 94 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 96 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 97 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 98 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 99 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 100 REGENERATIVE MEDICINE: ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 101 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 102 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 104 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 105 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 106 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 107 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 108 REGENERATIVE MEDICINE: CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 109 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 110 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 112 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 113 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 114 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 115 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 116 REGENERATIVE MEDICINE: JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 117 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 118 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 120 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 121 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 122 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 123 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 124 REGENERATIVE MEDICINE: INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 125 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 126 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 128 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 129 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 130 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 131 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 132 REGENERATIVE MEDICINE: SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 133 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 134 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 136 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 137 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 138 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 139 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 140 REGENERATIVE MEDICINE: TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 141 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 142 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 144 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 145 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 146 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 147 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 148 REGENERATIVE MEDICINE: PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 149 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 150 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 152 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 153 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 154 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 155 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 156 REGENERATIVE MEDICINE: INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 157 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 158 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 160 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 161 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 162 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 163 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 164 REGENERATIVE MEDICINE: THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 165 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 166 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 168 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 169 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 170 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 171 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 172 REGENERATIVE MEDICINE: MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 173 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 174 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 176 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 177 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 178 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 179 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 180 REGENERATIVE MEDICINE: SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 181 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 182 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 184 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 185 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 186 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 187 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 188 REGENERATIVE MEDICINE: HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 189 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 190 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 192 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 193 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 194 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 195 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 196 REGENERATIVE MEDICINE: AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 197 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 198 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 200 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 201 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 202 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 203 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 204 REGENERATIVE MEDICINE: REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 205 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 206 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 207 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 209 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 210 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 211 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 212 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 213 REGENERATIVE MEDICINE: REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 214 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 215 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 217 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 218 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 219 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 220 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 221 REGENERATIVE MEDICINE: MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 222 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 223 SOUTH AMERICATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018-2030 (USD MILLION)
• TABLE 225 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018-2030 (USD MILLION)
• TABLE 226 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018-2030 (USD MILLION)
• TABLE 227 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018-2030 (USD MILLION)
• TABLE 228 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 229 REGENERATIVE MEDICINE: SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018-2030 (USD MILLION)
• TABLE 230 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018-2030 (USD MILLION)
• TABLE 231 ACQUISITION
• TABLE 232 EXPANSION
• TABLE 233 PARTNERSHIP/AGREEMENT
• TABLE 234 PRODUCT LAUNCH/PRODUCT APPROVAL
• TABLE 235 PRODUCT DEVELOPMENT
• TABLE 236 COLLABORATION
• TABLE 237 COLD CHAIN TECHNOLOGIES, LLC: PRODUCTS OFFERED
• TABLE 238 COLD CHAIN TECHNOLOGIES, LLC: KEY DEVELOPMENTS
• TABLE 239 EMBALL'ISO: PRODUCTS OFFERED
• TABLE 240 INMARK INC: PRODUCTS OFFERED
• TABLE 241 SONOCO THERMOSAFE: PRODUCTS OFFERED
• TABLE 242 SONOCO THERMOSAFE: KEY DEVELOPMENTS
• TABLE 243 VA-Q-TEC AG: PRODUCTS OFFERED
• TABLE 244 VA-Q-TEC AG: KEY DEVELOPMENTS
• TABLE 245 DEUTSCHE BAHN AG: PRODUCTS OFFERED
• TABLE 246 DHL INTERNATIONAL GMBH: PRODUCTS OFFERED
• TABLE 247 DHL INTERNATIONAL GMBH: KEY DEVELOPMENTS
• TABLE 248 KUEHNE + NAGEL INC.: PRODUCTS OFFERED
• TABLE 249 KUEHNE + NAGEL INC.: KEY DEVELOPMENTS
• TABLE 250 UNITED PARCEL SERVICE OF AMERICA, INC.: PRODUCTS OFFERED
• TABLE 251 UNITED PARCEL SERVICE OF AMERICA, INC.: KEY DEVELOPMENTS
• TABLE 252 KANEKA CORPORATION: PRODUCTS OFFERED
• TABLE 253 KANEKA CORPORATION: KEY DEVELOPMENTS
• TABLE 254 CSAFE GLOBAL: PRODUCTS OFFERED
• TABLE 255 CSAFE GLOBAL: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS
• FIGURE 2 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PRODUCT
• FIGURE 3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TYPE
• FIGURE 4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TEMPERATURE RANGE
• FIGURE 5 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PAYLOAD CAPACITY
• FIGURE 6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY USE
• FIGURE 7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY MEDICINE TYPE
• FIGURE 8 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS BY END USE INDUSTRY
• FIGURE 9 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET: MARKET STRUCTURE
• FIGURE 10 RESEARCH PROCESS OF MRFR
• FIGURE 11 MARKET DYNAMICS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
• FIGURE 12 DRIVER IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET
• FIGURE 13 RESTRAINT IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET
• FIGURE 14 PORTER'S FIVE FORCES ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
• FIGURE 15 SUPPLY CHAIN ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
• FIGURE 16 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2023 (% SHARE)
• FIGURE 17 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
• FIGURE 18 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2023 (% SHARE)
• FIGURE 19 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2018-2030 (USD MILLION)
• FIGURE 20 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2023 (% SHARE)
• FIGURE 21 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• FIGURE 22 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2023 (% SHARE)
• FIGURE 23 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2018-2030 (USD MILLION)
• FIGURE 24 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2023 (% SHARE)
• FIGURE 25 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2018-2030 (USD MILLION)
• FIGURE 26 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2023 (% SHARE)
• FIGURE 27 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2018-2030 (USD MILLION)
• FIGURE 28 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2023 (% SHARE)
• FIGURE 29 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
• FIGURE 30 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2023 (% SHARE)
• FIGURE 31 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018-2027
• FIGURE 32 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 33 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 34 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 35 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 36 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 37 MARKET SHARE ANALYSIS,
• FIGURE 38 COLD CHAIN TECHNOLOGIES, LLC: SWOT ANALYSIS
• FIGURE 39 EMBALL'ISO: SWOT ANALYSIS
• FIGURE 40 INMARK, LLC: SWOT ANALYSIS
• FIGURE 41 SONOCO THERMOSAFE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 42 SONOCO THERMOSAFE: SWOT ANALYSIS
• FIGURE 43 VA-Q-TEC AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 44 VA-Q-TEC AG: SWOT ANALYSIS
• FIGURE 45 DEUTSCHE BAHN AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 46 DEUTSCHE BAHN AG: SWOT ANALYSIS
• FIGURE 47 DHL INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 48 DHL INTERNATIONAL GMBH: SWOT ANALYSIS
• FIGURE 49 KUEHNE + NAGEL INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 50 KUEHNE + NAGEL INC.: SWOT ANALYSIS
• FIGURE 51 UNITED PARCEL SERVICE OF AMERICA, INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 52 UNITED PARCEL SERVICE OF AMERICA, INC.: SWOT ANALYSIS
• FIGURE 53 KANEKA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 54 KANEKA CORPORATION: SWOT ANALYSIS
• FIGURE 55 CSAFE GLOBAL: SWOT ANALYSIS

Global Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product (Shippers and Containers), by Type (Active System and Passive System), by Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine), by End-use Industry (Pharmaceuticals and Clinical Trails), and by Region (North America, Europe, Asia Pacific, and Rest of the World) - Forecast Till 2030

Market Overview

A compound annual growth rate (CAGR) of 9.2% is anticipated for the Global Temperature-controlled Packaging for Pharmaceutical industry during the forecast period.

The Temperature-controlled Packaging for Pharmaceutical Market is being driven by the Pharmaceutical Industry's growth, the adoption of intelligent cold chain technology, and a variety of government initiatives to support the regional pharmaceutical industry.

The expansion of temperature-controlled packaging for the pharmaceutical market has been facilitated by the increasing demand for packaging in the pharmaceutical industry. Temperature-controlled packaging for pharmaceuticals is intended to ensure that sensitive products are maintained at the appropriate temperature. The healthcare industry is the primary application of these packaging solutions for the transportation and storage of temperature-sensitive products in a controlled temperature environment.

Market segment insights

The Temperature-controlled Packaging for Pharmaceutical Market is segmented into Shippers and Containers based on the product.

The market is segmented into Active System and Passive System based on type.

The Pharmaceutical Market's Temperature-controlled Packaging is segmented into the following categories: -20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C.

The market is segmented into five categories: Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L, all of which are based on payload capacity.

The Temperature-controlled Packaging for Pharmaceutical Market is categorized as either Single Use or Reusable, depending on its intended use.

The Temperature-controlled Packaging for Pharmaceutical Market is segmented into Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine, based on the type of medicine.

The Market is segmented into Pharmaceuticals and Clinical Trials based on the end use industry.

Regional Perspectives

In 2023, North America held the largest market share and is anticipated to experience the highest compound annual growth rate (CAGR) during the forecast period. North America is anticipated to be a highly profitable market during the forecast period as a result of the high disposable income levels, numerous patients, and a variety of lifestyle disorders. A expanding geriatric population, in conjunction with pharmaceutical product safety regulations, may increase regional market demand. Increased international trade and bilateral trade agreements may be advantageous to the market.

Asia Pacific has the second largest market share in the global temperature-controlled packaging for pharmaceuticals. It is expected to increase at a revenue-based CAGR during the forecast period. APAC is considered to be highly profitable due to the increase in infectious diseases and the need for cold chain solutions to preserve vaccines. In order to optimize their financial revenues, the Temperature-controlled Packaging for Pharmaceutical Market's most prominent participants may concentrate on the highly promising Asian countries.

In 2017, the European Union (EU) authorities implemented a series of new criteria for pharmaceutical packaging that were directed at counterfeit pharmaceuticals. It is anticipated that Europe will experience substantial growth during the projection period. EU authorities have implemented anti-counterfeiting technologies, including overt, clandestine, and forensic technology, in pharmaceutical packaging. As a result, pharmaceutical packaging companies in the region are continuing to refine their packaging methods and procedures.

Africa, South America, and the Middle East comprise the Rest of the World. The Middle East & Africa market is anticipated to experience a substantial increase in the coming years due to the increasing per capita disposable income, healthcare awareness, and pharmaceutical and drug consumption.

Major Players

Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, kaneka Corporation, DHL International GmbH, Deutsche Bahn AG, Cold Chain Technologies, LLC, EMBALL'ISO, Inmark, LLC, kuehne + nagel inc., and CSafe Globalva-Q-tec AG are among the key companies in the Temperature-controlled Packaging for Pharmaceutical Market.

TABLE OF CONTENTS

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS

1. EXECUTIVE'S HANDBOOK

• 1.1. THE TOP PERFORMING SEGMENTS
• 1.2. KEY TRENDS SUMMARIZED
• 1.3. PRICING OUTLOOK
• 1.4. STRATEGIC INSIGHTS
• 1.5. WHO ARE THE KEY PLAYERS IN THE MARKET?

SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. REPORT SEGMENTATION & SCOPE
• 2.3. REGIONAL & COUNTRY LEVEL COVERAGE
• 2.4. WHY YOU NEED THIS REPORT?

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA FLOW
  • 3.2.1. DATA MINING PROCESS
• 3.3. PURCHASED DATABASE:
• 3.4. SECONDARY SOURCES:
  • 3.4.1. SECONDARY RESEARCH DATA FLOW:
• 3.5. PRIMARY RESEARCH:
  • 3.5.1. PRIMARY RESEARCH DATA FLOW:
  • 3.5.2. PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3. PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6. APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1. REVENUE ANALYSIS APPROACH
• 3.7. DATA FORECASTING
  • 3.7.1. DATA FORECASTING TECHNIQUE
• 3.8. DATA MODELING
  • 3.8.1. MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2. DATA MODELING:
• 3.9. TEAMS AND ANALYST CONTRIBUTION

SECTION III: QUALITATIVE ANALYSIS

4. MARKET DYNAMICS

• 4.1. INTRODUCTION
• 4.2. GROWTH PARAMETERS MAPPED - DRIVERS
  • 4.2.1. GROWTH IN THE PHARMACEUTICAL INDUSTRY SUPPLEMENTING SALES TO THE SIGNIFICANT EXTENT
  • 4.2.2. ADOPTION OF SMARTER COLD CHAIN TECHNOLOGY
• 4.3. WHAT ARE THE CHALLENGES FACED BY INDUSTRY PARTICIPANTS?
  • 4.3.1. RISE IN RAW MATERIAL COSTS
• 4.4. OPPORTUNITIES
  • 4.4.1. VARIOUS GOVERNMENT INITIATIVES ARE CARRIED OUT BY VARIOUS COUNTRIES TO BOOST THE PHARMACEUTICAL INDUSTRY.
• 4.5. IMPACT ANALYSIS OF COVID-19
  • 4.5.1 ECONOMIC IMPACT
    • 4.5.1.1 IMPACT ON THE PACKAGING INDUSTRY
  • 4.5.2 IMPACT ON PRODUCTION
  • 4.5.3 IMPACT ON TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY
    • 4.5.3.1 IMPACT ON SUPPLY CHAIN
    • 4.5.3.2 IMPACT ON RAW MATERIALS
    • 4.5.3.3 CASH FLOW CONSTRAINTS
  • 4.5.1. IMPACT ON WORLD TRADE

5. MARKET FACTOR ANALYSIS

• 5.1. SUPPLY/VALUE CHAIN ANALYSIS
  • 5.1.1. PARTICIPANTS
  • 5.1.2. VALUE PERCOLATION ACROSS THE CHAIN
  • 5.1.3. INTEGRATION LEVELS
  • 5.1.4. KEY ISSUES ADDRESSED
• 5.2. PORTER'S FIVE FORCES MODEL
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY

SECTION IV: QUANTITATIVE ANALYSIS

6. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT

• 6.1. INTRODUCTION
• 6.2. SHIPPERS
• 6.3. CONTAINERS

7. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE

• 7.1. AUTOMOTIVE
• 7.2. ACTIVE SYSTEM
• 7.3. PASSIVE SYSTEM

8. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE

• 8.1. INTRODUCTION
• 8.2. -20°C AND BELOW
• 8.3. -20°C TO 0°C
• 8.4. 2°C TO 8°C
• 8.5. 8°C TO 25°C
• 8.6. ABOVE 25°C

9. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY

• 9.1. INTRODUCTION
• 9.2. UP TO 10 L
• 9.3. 10 L - 20 L
• 9.4. 20 L - 40 L
• 9.5. 40 L - 150 L
• 9.6. ABOVE 150 L

10. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE

• 10.1. INTRODUCTION
• 10.2. SINGLE USE
• 10.3. REUSABLE

11. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE

• 11.1. INTRODUCTION
• 11.2. TEMPERATURE SENSITIVE PHARMACEUTICAL DRUGS
• 11.3. VACCINE
• 11.4. REGENERATIVE MEDICINE

12. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY

• 12.1. INTRODUCTION
• 12.2. PHARMACEUTICALS
• 12.3. CLINICAL TRAILS

13. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION

• 13.1. INTRODUCTION
• 13.2. NORTH AMERICA
  • 13.2.1. U.S.
  • 13.2.2. CANADA
• 13.3. EUROPE
  • 13.3.1. GERMANY
  • 13.3.2. FRANCE
  • 13.3.3. U.K.
  • 13.3.4. ITALY
  • 13.3.5. SPAIN
  • 13.3.6. REST OF EUROPE
• 13.4. ASIA PACIFIC
  • 13.4.1. CHINA
  • 13.4.2. JAPAN
  • 13.4.3. INDIA
  • 13.4.4. SOUTH KOREA
  • 13.4.5. TAIWAN
  • 13.4.6. PHILIPPINES
  • 13.4.7. INDONESIA
  • 13.4.8. THAILAND
  • 13.4.9. MALAYSIA
  • 13.4.10. SINGAPORE
  • 13.4.11. HONG KONG
  • 13.4.12. AUSTRALIA
  • 13.4.13. REST OF ASIA-PACIFIC
• 13.5. REST OF THE WORLD
  • 13.5.1. MIDDLE EAST & AFRICA
  • 13.5.2. SOUTH AMERICA

SECTION V: COMPETITIVE ANALYSIS

14. COMPETITIVE LANDSCAPE

• 14.1. INTRODUCTION
• 14.2. COMPETITION DASHBOARD
• 14.3. COMPANY MARKET SHARE ANALYSIS,
• 14.4. WHO ARE THE MARKET DISRUPTORS & INNOVATORS?
• 14.5. WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS?
• 14.6. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MARKET
• 14.7. COMPETITIVE BENCHMARKING
• 14.8. PUBLIC PLAYERS STOCK SUMMARY
• 14.9. COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
• 14.10. KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 14.10.1. PRODUCT DEVELOPMENTS
  • 14.10.2. MERGER & ACQUISITION
  • 14.10.3. EXPANSION

15. COMPANY PROFILES

• 15.1. COLD CHAIN TECHNOLOGIES, LLC
  • 15.1.1. COMPANY OVERVIEW
  • 15.1.2. FINANCIAL OVERVIEW
  • 15.1.3. PRODUCT OFFERED
  • 15.1.4. KEY DEVELOPMENTS
  • 15.1.5. SWOT ANALYSIS
  • 15.1.6. KEY STRATEGIES
• 15.2. EMBALL'ISO
  • 15.2.1. COMPANY OVERVIEW
  • 15.2.2. FINANCIAL OVERVIEW
  • 15.2.3. PRODUCT OFFERED
  • 15.2.4. KEY DEVELOPMENTS
  • 15.2.5. SWOT ANALYSIS
  • 15.2.6. KEY STRATEGIES
• 15.3. INMARK, LLC
  • 15.3.1. COMPANY OVERVIEW
  • 15.3.2. FINANCIAL OVERVIEW
  • 15.3.3. PRODUCT OFFERED
  • 15.3.4. KEY DEVELOPMENTS
  • 15.3.5. SWOT ANALYSIS
  • 15.3.6. KEY STRATEGIES
• 15.4. SONOCO THERMOSAFE
  • 15.4.1. COMPANY OVERVIEW
  • 15.4.2. FINANCIAL OVERVIEW
  • 15.4.3. PRODUCT OFFERED
  • 15.4.4. KEY DEVELOPMENTS
  • 15.4.5. SWOT ANALYSIS
  • 15.4.6. KEY STRATEGIES
• 15.5. VA-Q-TEC AG
  • 15.5.1. COMPANY OVERVIEW
  • 15.5.2. FINANCIAL OVERVIEW
  • 15.5.3. PRODUCT OFFERED
  • 15.5.4. KEY DEVELOPMENTS
  • 15.5.5. SWOT ANALYSIS
  • 15.5.6. KEY STRATEGIES
• 15.6. DEUTSCHE BAHN AG
  • 15.6.1. COMPANY OVERVIEW
  • 15.6.2. FINANCIAL OVERVIEW
  • 15.6.3. PRODUCT OFFERED
  • 15.6.4. KEY DEVELOPMENTS
  • 15.6.5. SWOT ANALYSIS
  • 15.6.6. KEY STRATEGIES
• 15.7. DHL INTERNATIONAL GMBH
  • 15.7.1. COMPANY OVERVIEW
  • 15.7.2. FINANCIAL OVERVIEW
  • 15.7.3. PRODUCT OFFERED
  • 15.7.4. KEY DEVELOPMENTS
  • 15.7.5. SWOT ANALYSIS
  • 15.7.6. KEY STRATEGIES
• 15.8. KUEHNE + NAGEL INC.
  • 15.8.1. COMPANY OVERVIEW
  • 15.8.2. FINANCIAL OVERVIEW
  • 15.8.3. PRODUCT OFFERED
  • 15.8.4. KEY DEVELOPMENTS
  • 15.8.5. SWOT ANALYSIS
  • 15.8.6. KEY STRATEGIES
• 15.9. UNITED PARCEL SERVICE OF AMERICA, INC.
  • 15.9.1. COMPANY OVERVIEW
  • 15.9.2. FINANCIAL OVERVIEW
  • 15.9.3. PRODUCT OFFERED
  • 15.9.4. KEY DEVELOPMENTS
  • 15.9.5. SWOT ANALYSIS
  • 15.9.6. KEY STRATEGIES
• 15.10. KANEKA CORPORATION
  • 15.10.1. COMPANY OVERVIEW
  • 15.10.2. FINANCIAL OVERVIEW
  • 15.10.3. PRODUCT OFFERED
  • 15.10.4. KEY DEVELOPMENTS
  • 15.10.5. SWOT ANALYSIS
  • 15.10.6. KEY STRATEGIES
• 15.11. CSAFE GLOBAL
  • 15.11.1. COMPANY OVERVIEW
  • 15.11.2. FINANCIAL OVERVIEW
  • 15.11.3. PRODUCT OFFERED
  • 15.11.4. KEY DEVELOPMENTS
  • 15.11.5. SWOT ANALYSIS
  • 15.11.6. KEY STRATEGIES

16. RECOMMENDATIONS & EXPERT INSIGHTS

• 16.1. WHAT IS THE SHORT-TERM VS LONG-TERM OUTLOOK FOR MARKET?
• 16.2. WHO ARE THE PLAYERS TO LOOK OUT FOR?
• 16.3. WHAT WILL THE PRODUCT MIX LOOK IN COMING YEARS?

17. MRFR OFFERINGS & TEAM

• 17.1. CITATIONS & MEDIA
• 17.2. OUR REGIONAL REPRESENTATIVES
• 17.3. RELATED REPORTS
• 17.4. OUR DOMAIN COVERAGE